Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Barrett

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and PreventionStephanie E Barrett, Ryan S Teller, Seth P Forster, et al.
Pharmaceutical Research|February 22, 2023
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working GroupAndrea Bauer, Philippe Berben, Sudhir S Chakravarthi, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2014
Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugatesStephanie E Barrett, Rob S Burke, Marc T Abrams, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and PreventionStephanie E Barrett, Ryan S Teller, Seth P Forster, et al.
Pharmaceutical Research|February 22, 2023
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working GroupAndrea Bauer, Philippe Berben, Sudhir S Chakravarthi, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2014
Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugatesStephanie E Barrett, Rob S Burke, Marc T Abrams, et al.
Pageof 2